Optimizing Infection Control to Improve Outcomes of Allogeneic Stem Cell Transplant

home / peer-exchange / transplant-infection-control
Need for Infection Control in Patients Receiving High-Dose Therapy and Allogeneic Transplant

EP. 1: Need for Infection Control in Patients Receiving High-Dose Therapy and Allogeneic Transplant

January 16th 2017
Azoles for Prophylaxis of Invasive Fungal Infections in Transplant Patients

EP. 2: Azoles for Prophylaxis of Invasive Fungal Infections in Transplant Patients

January 16th 2017
Monitoring Azole Levels in Transplant Patients

EP. 3: Monitoring Azole Levels in Transplant Patients

January 16th 2017
Morbidity from CMV Infection in Transplant Patients

EP. 4: Morbidity from CMV Infection in Transplant Patients

January 16th 2017
The Need for CMV Prophylaxis in the Transplant Setting

EP. 5: The Need for CMV Prophylaxis in the Transplant Setting

January 16th 2017
Letermovir for CMV Prophylaxis in Transplant Patients

EP. 6: Letermovir for CMV Prophylaxis in Transplant Patients

January 16th 2017
Letermovir Phase III Trial

EP. 7: Letermovir Phase III Trial

January 16th 2017